Maxime Chénard-Poirier

4PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia

|Mar 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.

Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez

|Jan 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Sarah Halford, Gareth J Veal, Stephen R Wedge

Pageof 1